Trial Profile
An exploratory, randomised, open-label, two-period, crossover study in healthy subjects to evaluate the effect of ketoconazole on the pharmacokinetics of SMP-028
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Feb 2023
Price :
$35
*
At a glance
- Drugs SMP 028 (Primary) ; Ketoconazole
- Indications Allergic rhinitis; Asthma
- Focus Pharmacokinetics
- Sponsors Dainippon Sumitomo Pharma
- 30 Jun 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 20 Apr 2010 New trial record